Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Diabetes Research and Clinical Practice|April 11, 2022
A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group on Diabetes and TechnologySergio Di Molfetta, Antonio Rossi, Roberta Assaloni, et al.
Cardiovascular Diabetology|June 13, 2025
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetesPaola Giustina Simeone, Sarah Costantino, Rossella Liani, et al.
Acta Diabetologica|June 3, 2024
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetesStefano Ciardullo, Mario Luca Morieri, Giuseppe Daniele, et al.
Clinical Therapeutics|August 6, 2020
Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world SettingGiulia Di Dalmazi, Sara Coluzzi, Maria P A Baldassarre, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 6, 2021
Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetesFrancesco Vadini, Paola G Simeone, Giovambattista Desideri, et al.
Frontiers in Endocrinology|August 1, 2022
Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 DiabetesGiulia Di Dalmazi, Sara Coluzzi, Maria Pompea Antonia Baldassarre, et al.
Recenti Progressi in Medicina|March 22, 2022
[Unmet clinical need and new therapeutic options.]Francesca Caprari, Alessandro Alfano, Giuliano Buzzetti, et al.
Scientific Reports|February 19, 2021
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetesDonato Santovito, Lisa Toto, Velia De Nardis, et al.
Plos One|May 5, 2012
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivityFrancesco Andreozzi, Ivan Presta, Gaia Chiara Mannino, et al.
Cardiovascular Diabetology|April 29, 2024
Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitusHelene Grannes, Thor Ueland, Paola Simeone, et al.
Pageof 10